Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Revenue projections:

Revenue projections for SOLV
Revenue projections for SOLV

Revenues for SOLV are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 1.231000
forwardPE 9.986201
debtToEquity 103.941000
earningsGrowth 1.008000
revenueGrowth -0.037000
grossMargins 0.535620
operatingMargins 0.044040
trailingEps 8.880000
forwardEps 7.087780

SOLV's current ratio of 1.231 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. SOLV's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
Solventum Corporation's elevated debt-to-equity ratio reflects a high level of debt relative to equity, signaling that the company is heavily leveraged. This reliance on debt could increase financial risk in periods of economic uncertainty.
SOLV's forward EPS being lower than its trailing EPS suggests that the company is expected to see a decline in profitability. This signals that the company may face a challenging financial year ahead.

Price projections:

Price projections for SOLV
Price projections for SOLV

Over time, price projections for SOLV have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for SOLV's continued growth.

Insider Transactions:

Insider Transactions for SOLV
Insider Transactions for SOLV


SOLV experienced 1 sell transactions with market price of 71.41999816894531 per share.Throughout the period under consideration, there were no sell transactions.The recent trend of increased buying at SOLV's current price levels may indicate a favorable market sentiment. This could point to a positive outlook for the stock, as investors show growing confidence through higher buy activity.

Recommendation changes over time:

Recommendations trend for SOLV
Recommendations trend for SOLV


SOLV has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view SOLV as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.